
|
WEEKLY REPORT |
|---|
|
Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019 Continued surveillance for C. auris, prudent antifungal use, and susceptibility testing for all C. auris clinical isolates needed. |
|---|
|
|
|---|
|
|
|---|
|
QUICKSTATS |
|---|
|
CONTINUING EDUCATION |
|---|
|
|
|---|


